1 / 18

Mi Pet-Making joint support tasty!

Mi Pet-Making joint support tasty!. Presented by . Active+ THE dedicated CVS joint supplement. JOINT SUPPORT NEUTRACEUTICALS, THE KEY QUESTIONS. Are owners and members of the practice aware of the potential benefits for dogs?

zulema
Download Presentation

Mi Pet-Making joint support tasty!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mi Pet-Making joint support tasty! Presented by

  2. Active+ THE dedicated CVS joint supplement

  3. JOINT SUPPORT NEUTRACEUTICALS, THE KEY QUESTIONS • Are owners and members of the practice aware of the potential benefits for dogs? • Are you concerned about the effects of alternative long-term therapies? • Do you work hard to sell the first pot then not see repeat business? • Is compliance a problem with dogs or owners becoming bored and resistant to long term administration? • How many sales do you lose to the high street or internet?

  4. Active+ and Healthy Pets Club • The joint supplement of choice within the HPC lifetime care medication scheme. • The dedicated joint supplement within CVS. • Allows clients 20% discount on normal cost. • Assists in facilitating long term supplement provision and client loyalty. • Acts as an overall joint support package and assists in a comprehensive multimodal osteoarthritictreatment plan.

  5. Joint support nutraceuticals • Naturally occurring biological supplements that may confer some degree of health benefit. • High palatability enhances acceptance and facilitates compliance. • Most important components to consider are: Omega-3 series polyunsaturated fatty acids(PUFAs). Joint support nutrients glucosamine and chondroitin. • Green Lipped Muscle(GLM) contains high levels of Omega-3(PUFAs) and Glycosaminoglycans. Benefits are well documented.

  6. P.E.T.S. Consider 4 important categories relevant to nutraceutical usage. • Product quality. • Effects. • Tolerance. • Safety.

  7. Product quality • Ingredients of Active+ comply with Pharmacopoeia standards. • Green lipped mussel is sustainably farmed and cold processed to protect ingredient quality. • Active + chews are manufactured in a facility which is audited to strict US standards. • New packaging features enhanced airtight seal on the tub to protect the contents.

  8. Soft chews are cured not baked

  9. SOOTHING STIFF JOINTS AND MAINTAINING MOBILITY, WILL IMPROVE DEMEANOUR

  10. OSTEOARTHRITIS • Is a slowly progressive irreversible disorder of moveable joints. • Cartilage deteriorates,osteophytesform,boneremodels,periarticular tissues change and inflammation occurs. • >20% of dogs over 1 year of age affected • Cartilage is aneural. • Pain is associated with periarticular tissue alteration and altered pain processing. • Owners may underestimate pain levels.

  11. GLM-EFFICACY • On Veterinary Request further information is available regarding efficacy. • Essentially the Omega-3 PUFAs in GLM inhibit the Eicosanoids(inflammatory mediators) production from Arachidonic acid metabolism. • This is mediated by their inhibitory effects on Cyclooxygenase and Lipoxygenase. • Decreased production of harmful prostagladins and leukotrienes results. • GAG content may offer chondroprotection.

  12. WHAT’S AN EICOSANOID? • An oxygenated derivative of a 20 carbon EFA. • >20 different Eicosanoids controlling a wide array of cellular functions especially inflammation, immunity and the central nervous system. • Parallel and competing pathways from the EFA’s. • Arachidonic Acid is the most pro-inflammatory and is an Omega-6 PUFA. • High levels of Omega-3 PUFA can help minimise the Arachidonic Acid Cascade.

  13. Arachidonic Acid Cascade GLM: Omega-3 PUFAs (ETA,DHA) Inhibit ARACHIDONIC ACID Cyclooxygenase Cox 1,Cox 2 Lipoxygenase Lox-5 Prostaglandines Leukotrienes

  14. SO HOW DO OMEGA 3’s WORK? • DISPLACEMENT-Dietary O3 decreases tissue concentration of AA and thus less is available to form O6eicosanoids. • COMPETITIVE INHIBITION-DGLA and EPA compete with AA for cyclooxygenase and lipoxygenase enzymes thus lowering the output of AA eicosanoids. • COUNTERACTION-Some DGLA and EPA derived eicosanoids counteract their AA derived counterparts.

  15. PRACTICAL USEAGE GLM • In patients with early osteoarthritis (STIFF JOINTS). • In at risk categories of pet-those prone to hip/elbow dysplasia • Giant breeds as a potential preventative measure (JOINT SUPPORT) • Highly active breeds e.g. Flyball, Working dogs • Synergistically with NSAIDS e.g.carprofen. • As part of a six point plan for osteoarthritis.

  16. The Six Point Plan • Analgesia • Bodyweight • Comfort (e.g. floor surfaces, car ramps) • Diet • Exercise • Follow-up

  17. The Six Point Plan cont • Allows a multimodal approach to be set up easily. • All members in the team act with the same guide. • Different members have different roles to play. • The owner can be informed and guided easily. • Evolution of care progresses with the disease.

  18. MANY THANKS FOR YOUR ATTENTION ANY QUESTIONS?

More Related